These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9413429)

  • 1. Cytotoxic therapy in systemic lupus erythematosus. Experience from a single center.
    Rahman P; Humphrey-Murto S; Gladman DD; Urowitz MB
    Medicine (Baltimore); 1997 Nov; 76(6):432-7. PubMed ID: 9413429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Methylprednisolone and cyclophosphamide pulse therapy of severe systemic lupus erythematosus in children].
    Hu J; Li CW; Zhang X; Pi SH; Zhao JS; Chen XY; Liu Y
    Zhonghua Er Ke Za Zhi; 2003 Jun; 41(6):430-4. PubMed ID: 14748998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term therapy of immunologic diseases with special reference to the use of immunosuppressive agents].
    Scheiffarth F; Warnatz H
    Dtsch Med Wochenschr; 1969 Nov; 94(47):2444-9. PubMed ID: 4310731
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunosuppressive therapy. 1.
    Skinner MD; Schwartz RS
    N Engl J Med; 1972 Aug; 287(5):221-7. PubMed ID: 4556641
    [No Abstract]   [Full Text] [Related]  

  • 5. Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus.
    Buratti S; Szer IS; Spencer CH; Bartosh S; Reiff A
    J Rheumatol; 2001 Sep; 28(9):2103-8. PubMed ID: 11550982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disseminated cytomegalovirus infection complicating active treatment of systemic lupus erythematosus: an emerging problem.
    Berman N; Belmont HM
    Lupus; 2017 Apr; 26(4):431-434. PubMed ID: 27703052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience with mycophenolate mofetil as maintenance therapy in five pediatric patients with severe systemic lupus erythematosus.
    Dittrich K; Ross S; Benz K; Amann K; Dötsch J
    Klin Padiatr; 2009 Dec; 221(7):425-9. PubMed ID: 20013565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antimetabolites in complex treatment of systemic lupus erythematosus in children].
    Isaeva LA; Kartasheva VI
    Pediatriia; 1974 Nov; (11):40-8. PubMed ID: 4444879
    [No Abstract]   [Full Text] [Related]  

  • 9. [Combination of antimetabolites and alkylating agents in the treatment of advanced breast cancer].
    Germiniani R; Pipino G; Lavorato F; Bressani Doldi S
    Minerva Med; 1977 Mar; 68(13):831-4. PubMed ID: 321989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive and cytotoxic drugs in the treatment of rheumatic skin disorders.
    Callen JP
    Semin Cutan Med Surg; 2001 Mar; 20(1):58-68. PubMed ID: 11308138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents.
    Karim MY; Alba P; Cuadrado MJ; Abbs IC; D'Cruz DP; Khamashta MA; Hughes GR
    Rheumatology (Oxford); 2002 Aug; 41(8):876-82. PubMed ID: 12154204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent developments in chemotherapy of malignancy.
    Bertino JR
    Laryngoscope; 1975 Mar; 85(3):491-8. PubMed ID: 1091794
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytotoxic drug treatment of lupus nephritis.
    Donadio JV; Holley KE; Ilstrup DM
    Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):178-81. PubMed ID: 7102666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does mycophenolate mofetil prevent extra-renal flares in systemic lupus erythematosus? Results from an observational study of patients in a single practice treated for up to 5 years.
    Posalski JD; Ishimori Ml; Wallace DJ; Weisman MH
    Lupus; 2009 May; 18(6):516-21. PubMed ID: 19395453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Remote results of combined immunosuppressive treatment of systemic lupus erythematosus (1969-1978)].
    Wysocka K; Kiczak J; Hawrlylak E
    Wiad Lek; 1979 Nov; 32(22):1591-4. PubMed ID: 538910
    [No Abstract]   [Full Text] [Related]  

  • 16. Cancer chemotherapy. II. Results of 603 courses of therapy in 400 consecutive patients, followed for 18-52 months.
    Hill GJ; Larsen RR; Sas EM; Cohen BI; Irish TJ; Kandel E; Kogler J
    Oncology; 1973; 27(2):137-52. PubMed ID: 4701582
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug therapy of cervical cancer].
    Dekster LI
    Vopr Onkol; 1974; 20(8):94-102. PubMed ID: 4215223
    [No Abstract]   [Full Text] [Related]  

  • 18. Corticosteroid-sparing strategies in the treatment of retinal vasculitis in systemic lupus erythematosus.
    Neumann R; Foster CS
    Retina; 1995; 15(3):201-12. PubMed ID: 7569347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate in patients with moderate systemic lupus erythematosus (exclusion of renal and central nervous system disease).
    Gansauge S; Breitbart A; Rinaldi N; Schwarz-Eywill M
    Ann Rheum Dis; 1997 Jun; 56(6):382-5. PubMed ID: 9227169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Juvenile systemic lupus erythematosus in Portugal: clinical and immunological patterns of disease expression in a cohort of 56 patients.
    Cabral M; Escobar C; Conde M; Ramos M; Melo Gomes JA
    Acta Reumatol Port; 2013; 38(4):274-85. PubMed ID: 24435032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.